ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026
[Chinese expert consensus on the diagnosis and treatment of elderly patients with mantle cell lymphoma (2026)].
Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma that predominantly occurs in elderly patients. In China, the proportion of elderly patients with MCL is increasing with the aging of the general population. The emergence of new targeted drugs and novel approaches has changed the treatment patterns and prognosis of MCL. Meanwhile, due to poor tolerance, elderly patients require individualized treatment strategies based on a comprehensive geriatric assessment. Therefore, the Lymphoid Disease Group of the Chinese Society of Hematology, Chinese Medical Association, and the Lymphatic Disease Society of the Chinese Medical Education Association convened relevant experts to formulate this consensus, to improve the diagnosis and treatment levels of elderly patients with MCL in China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.